Survey 33 – Persistent Productive Cough in Adults

Survey 33 - Persistent Productive Cough in Adults

MCI Registration Number

FULL NAME (As in your Pancard)

Phone/Mobile

City

State

Speciality

Bank Details

Account Holder Name

A/c Number

IFSC Code

Upload Cancelled Cheque (Max Size - 2 MB)

Choose File

Pancard Number

Upload Pancard Details (Max Size - 2 MB)

Choose File

1. In your routine practice, what proportion of adult cough patients present with persistent productive cough (>3–4 weeks)?

Less than 10%

10–25%

26–50%

More than 50%

2. Which age group most commonly presents with persistent productive cough?

18–30 yrs

31–45 yrs

46–60 yrs

Less than 60 yrs

3. What are the most frequent patient-reported concerns associated with persistent productive cough? (Multiple options)

4. Which underlying causes do you most commonly associate with persistent productive cough in adults? (Rank top 3)

5. How strongly do you feel air pollution and occupational exposure contribute to persistent productive cough in your patients?

Minimal

Moderate

Significant

Very significant

6. After how many weeks of productive cough do you usually initiate detailed evaluation?

2 weeks

3–4 weeks

6 weeks

Based on symptom severity

7. Which investigations do you routinely consider in persistent productive cough? (Multiple options)

8. What clinical red flags prompt immediate investigation or referral? (Multiple options)

9. What is your preferred initial treatment approach for persistent productive cough?

Mucolytics alone

Expectorant + bronchodilator

Antibiotics (empirical)

Anti-inflammatory therapy

Step-wise therapy based on response

10. Quality of sputum clearance Reduction in cough frequency Prevention of exacerbations Safety for long-term use Patient compliance Evidence in chronic airway disease

11. In which clinical scenarios do you prefer using a combination of Levosalbutamol + Ambroxol + Guaiphenesin for persistent productive cough in adults?(Multiple options)

12. What key benefits do you most commonly observe with Levosalbutamol + Ambroxol + Guaiphenesin in persistent productive cough?

Faster sputum clearance

Reduced cough frequency

Improved breathing comfort

Reduced need for antibiotics

Better patient adherence

Early symptom relief

13. What would most help you reduce unnecessary antibiotic use in these patients?

Better mucolytic efficacy

Clearer guidelines

Diagnostic biomarkers

Patient education tool

14. What are the biggest challenges you face in managing persistent productive cough? (Multiple options)

I have read and agree to the Terms and Conditions .